LUTS, nocturia Flashcards

1
Q

nocturia

definition

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

polyuria

definition

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

nocturia index

nocturnal polyuria index
definitions

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is ADH

A

aquaporins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tea time Lasix in nocturia

efficacy

A

mean reduction 0.5
reduction of at least 1 episode 37%
NUCV reduces 18%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

nocturia

a blocker efficacy

A

similar to Lasix

Veterans study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

nocturia

anti cholinergics efficacy

A

reduction < 0.5

MA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is DDAVP and its efficacy

A

V2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CI to DDAVP

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SE OF DDAVP

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is BPH

A

Cunha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How common is BPH in autopsy series?

A

88% in 80s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How common is BPH in Asian men?

A

60s 40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is IPSS?

A
7 symptoms  (0 - 35)
1 QoL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How many patients have BOO when Qmax < 10

How many Qmax < 10 have BOO

A

70% (ICS-BPH study)

53%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is intravesical prostatic protrusion and cutoff?

A

150 - 250ml

PPV 94%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Natural hx of BPH

VA / OCS / MTOPS

A

.

18
Q

Forms of clinical progression

A

MTOPS

19
Q

Predictors of BPH progression

A

.

20
Q

Relationship between LUTS and vascular diseases

Study = ?

A

MSAM-7

21
Q

Physiology of UUO and BUO
Timing
Molecules involved

A

0 - 90min (PGE2, NO)
90min - 5h
> 5h (TXA2)

22
Q

Time for recovery after obstruction
Tubular fx
Glomerular fx

A

14d

3m

23
Q

WW for LUTS
Components =?
Efficacy =?

A

CONDUCT: IPSS 5 - 6

24
Q

a-blocker in BPH:

Efficacy

A

IPSS 4

Qmax 3

25
Q

ALLHAT study
Risk of combined CVD events : ___
Risk of CHF: ___
Risks of all-cause mortality: ___

A

25%
2X
NO

26
Q

5ARI for BPH : Efficacy:
IPSS
Qmax

A

IPSS 5 - 6

Qmax 2

27
Q

what is PLESS?

A

RRR 55% for AUR / BPH OT

28
Q
SE of 5ARI
Redcued libido: _
ED: _
Depression: _
Gynecomastia: _
A

6%
8%
10% higher
1%

29
Q
MTOPS results
IPSS: _
Qmax: _
AUR: _
OT: _
Clinical progression: _
A
7
4
81%
67%
66%
30
Q

Efficacy of PDE5i on BPH

A

IPSS 3 , IIEF

McVary

31
Q

Prostamol component and efficacy

A

Saw palmetto

Qmax

32
Q

HoLEP
Fiber size
Energy setting

A

550um

2J 50Hz

33
Q

HoLEP
Transfusion rate
Re-op rate

A
  1. 8%

0. 7% at 10y

34
Q

Mechanism of PVP

A

YAG, LBO
600um , side-firing
oxy-Hb
poor absorption by water

35
Q

what is the power of MoXy fiber?

A

180W

36
Q

UK-ROPE study for PAE: results
IPSS
Re-tx

A

10 points at 12m

5% at 1y, overall 20%

37
Q

Components of Urolift

A

3

38
Q

Rezum:

Each __second treatment delivers __ml water vapour

A

9s

0.42ml

39
Q

what is Memokath

A

nickel-titanium alloy

40
Q

what is iTIND?

A

nitinol; butterfly-like

41
Q

what is TUR syndrome

A

5

42
Q

Glycine 1.5%
Osmolality: _
Absorption rate: _

A

200mOsm/L

20ml/min